More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases

Fulgent (FLGT)
Investigations, Securities
By Andrea Farah
Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Fulgent Genetics Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”) for potential violations of federal […]

Distribution Solutions Group, Inc. (DSGR)
Investigations, Securities
By Andrea Farah
Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Distribution Solutions Group, Inc. (NASDAQ: DSGR) (“DSG” or the “Company”) for potential violations of […]

Xponential Fitness
Securities
By Andrea Farah
Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Xponential Fitness, Inc. (NYSE: XPOF) (“Xponential” or the “Company”) for potential violations of federal […]
News
Lowey Dannenberg Wins Class Certification in Ranbaxy Generic-Delay Case
On May 14, 2021, Judge Nathaniel M. Gorton of the U.S. District Court for the District of Massachusetts granted the End-Payor Plaintiffs’ (“EPPs’”) class certification motion. The EPPs are third party payors paying some or all of the purchase price for prescription…
Blog
Pharma Industry Takes Advantage of COVID Epidemic to Mislead Investors
Recently, several major players in the pharmaceutical industry have faced severe shareholder scrutiny for misleading the public regarding their roles in the production of COVID-19 vaccines. The company to most recently fall in the limelight is Emergent Biosolutions (“Emergent”). Emergent had…





